New Study Shows Significant Improvement in Cellulite and Skin Laxity with Advanced Minimally Invasive Treatment Utilizing Avéli® and Renuvion®

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to New Study Shows Significant Improvement in Cellulite and Skin Laxity with Advanced Minimally Invasive Treatment Utilizing Avéli® and Renuvion®
(NASDAQ: APYX) Delayed: 4.01 -0.1 (2.43%)
Previous Close $4.11    52 Week High $ 
Open $4.07    52 Week Low $ 
Day High $4.12    P/E N/A 
Day Low $3.93    EPS $ 
Volume 160,351